- TypeExhibition
- Location United States
- Date 11-11-2020 - 12-11-2020
Medical/Healthcare/Hospital
The exosome and EV-therapeutics industry is full of anticipation as the first few companies to reach clinical trials prepare to move ahead. As scientific understanding continues to grow and manufacturing methods constantly being fine-tuned, it’s now all about developing effective therapies to be the first to market.
The 2nd Digital Exosome Based Therapeutic Development Summit returns as your only industry platform to advance exosome-based therapeutics into a clinical and commercial reality. As the field begins to break into clinical trials, this must-attend conversation unites leading industry members to inform your therapeutic decision-making and progress robust pipelines in this exciting field.
Spanning 2 days, this digital meeting will focus exclusively on evidence-based therapeutic applications, helping industry leaders and newcomers alike overcome key challenges and engage in critical conversations about manufacturing, mechanisms of action, clinical progressions, partnerships, regulation and more. This meeting is tailor-made to address your most pressing questions and advance innovative candidates to the clinic and beyond.
Key Topics for 2020:
* Understanding the underlying mechanisms of exosome interactions to inform target identification and development decisions with Scripps Research and University Hospital Essen
* Exploring manufacturing methods to deliver clinically effective products and establish scalable processes with Aruna Bio and Exopharm
* Preparing for clinical trials with key lessons learned from the best in the business such as Aegle Therapeutics
* Developing beneficial partnerships and preparing internally to streamline commercialization and submissions with Evox Therapeutics, Codiak Biosciences and Exogenus Therapeutics
Brochure https://go.evvnt.com/670062-3?pid=6581
Speakers: Revital Aricha, Brainstorm Cell Therapeutics, Chris Baldwin, Exopharm Ltd., Heather Branscome, American Type Culture Collection and George Mason University, Xandra Breakefield, Harvard Medical School and Massachusetts General Hospital, Koen Breyne, Massachusetts General Hospital, Harvard Medical School, Richard Brudnick, Codiak Biosciences, Joana Correia, Exogenus Therapeutics SA, Joel de Beer, Anjarium Biosciences AG, Chulhee Choi, ILIAS Biologics Inc., Bernd Giebel, University Hospital Essen, Shelley Hartman, Aegle Therapeutics, Fatah Kashanchi, George Mason University, Per Lundin, Evox Therpaeutics, Linda Marbán, Capricor Therapeutics, Inc., Alex Mok, Mantra Bio, Guillaume van Niel, Université de Paris, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM, Eva Rohde, GMP Unit University Hospital and Paracelsus Medical University, Salzburg, Pranav Sharma, Scripps Research and Xosomix, Shaun Stapleton, ReNeuron, Steven Stice, Aruna Bio, Aijun Wang, University of California, Davis, Gareth Willis, Boston Children’s Hospital, Harvard Medical School
Time: 8:00 am - 5:00 pm